Table 1:
Parameter* | Stratum | Value (range) | Source |
---|---|---|---|
Population size | Overall | 100 000 | Wang et al. 202117§ |
Fraction in city A | 0.50 (0.20–0.80) | § | |
Fraction at higher risk | City A | 0.10 (0.01–0.50)¶ | Wang et al. 202117§ |
City B | 0.10 | Wang et al. 202117§ | |
Contact rate | Close nonsexual, all | 1 | Milwid et al.18§ |
Sexual, lower risk | 0.01 | Wang et al. 202117§ | |
Sexual, higher risk, city A | 0.189** (0.10–0.25)¶ | Wang et al. 2021,17§ Endo et al. 202219§ | |
Sexual, higher risk, city B | 0.189** | Wang et al. 2021,17§ Endo et al. 202219§ | |
Assortativity† | Cities, all contacts | 0.90 (0.70–1.0) | Armstrong et al. 202020§ |
Risk, close nonsexual | 0 | § | |
Risk, sexual | 0.50 | § | |
Per-contact SAR | Close nonsexual | 0.01†† | Beer and Bhargavi Rao 2019,21 Thornhill et al. 202222 |
Sexual | 0.90** | Endo et al. 202219§ | |
Initial infections | Overall | 10 | § |
Fraction in city A | 0.50 (0–1.0) | § | |
Duration of period | Latent or incubation | 8 | Thornhill et al. 2022,22 Miura et al. 2022,23 Charniga et al. 2022,24 Guzzetta et al. 202225 |
Infectious or symptoms | 21 | Thornhill et al. 2022,22 Adler et al. 202226 | |
Fraction of infectious period isolated | All | 0.50 | Thornhill et al. 2022,22 De Baetselier et al. 202227§ |
Vaccines available | All | 5000 | § |
Vaccine effectiveness‡ | All | 0.85 | NACI,2 Fine et al. 1988,28 CDC29 |
Vaccine prioritization sensitivity | Higher risk | 0.90 | Toronto Public Health3§ |
Vaccine allocation | City A | 0.50 (0–1.0)‡‡ | – |
Note: CDC = Centers for Disease Control and Prevention, NACI = National Advisory Committee on Immunization, R0 = basic reproduction number (epidemic potential), SAR = secondary attack rate.
All durations are in days; all rates are per day.
Fraction of contacts formed exclusively within group;30 0 implies random mixing between groups and 1 implies no mixing.
Leaky type: partial protection among all vaccinated, not full protection among a fraction vaccinated.
Assumed or representative.
Calculated to fit R0 = 1.5, reflecting prevaccination estimate of monkeypox virus R0 in Ontario14 using EpiNow2.10
Calibrated to fit about 95% incidence via sexual versus close nonsexual contacts.
Optimized parameter.